294 related articles for article (PubMed ID: 25078947)
1. A correlate of HIV-1 control consisting of both innate and adaptive immune parameters best predicts viral load by multivariable analysis in HIV-1 infected viremic controllers and chronically-infected non-controllers.
Tomescu C; Liu Q; Ross BN; Yin X; Lynn K; Mounzer KC; Kostman JR; Montaner LJ
PLoS One; 2014; 9(7):e103209. PubMed ID: 25078947
[TBL] [Abstract][Full Text] [Related]
2. Disease Progression in HIV-1-Infected Viremic Controllers.
Groves KC; Bibby DF; Clark DA; Isaksen A; Deayton JR; Anderson J; Orkin C; Stagg AJ; McKnight A
J Acquir Immune Defic Syndr; 2012 Dec; 61(4):407-16. PubMed ID: 22902723
[TBL] [Abstract][Full Text] [Related]
3. Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers.
Tomescu C; Duh FM; Hoh R; Viviani A; Harvill K; Martin MP; Carrington M; Deeks SG; Montaner LJ
AIDS; 2012 Sep; 26(15):1869-78. PubMed ID: 22874514
[TBL] [Abstract][Full Text] [Related]
4. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of Abrupt Loss of Virus Control in a Cohort of Previous HIV Controllers.
Rosás-Umbert M; Llano A; Bellido R; Olvera A; Ruiz-Riol M; Rocafort M; Fernández MA; Cobarsi P; Crespo M; Dorrell L; Del Romero J; Alcami J; Paredes R; Brander C; Mothe B
J Virol; 2019 Feb; 93(4):. PubMed ID: 30487276
[TBL] [Abstract][Full Text] [Related]
6. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.
Emu B; Sinclair E; Hatano H; Ferre A; Shacklett B; Martin JN; McCune JM; Deeks SG
J Virol; 2008 Jun; 82(11):5398-407. PubMed ID: 18353945
[TBL] [Abstract][Full Text] [Related]
7. Baseline viral load and immune activation determine the extent of reconstitution of innate immune effectors in HIV-1-infected subjects undergoing antiretroviral treatment.
Chehimi J; Azzoni L; Farabaugh M; Creer SA; Tomescu C; Hancock A; Mackiewicz A; D'Alessandro L; Ghanekar S; Foulkes AS; Mounzer K; Kostman J; Montaner LJ
J Immunol; 2007 Aug; 179(4):2642-50. PubMed ID: 17675528
[TBL] [Abstract][Full Text] [Related]
8. Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses.
Salgado M; Garcia-Minambres A; Dalmau J; Jiménez-Moyano E; Viciana P; Alejos B; Clotet B; Prado JG; Martinez-Picado J
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593044
[TBL] [Abstract][Full Text] [Related]
9. Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients.
Witwer KW; Watson AK; Blankson JN; Clements JE
Retrovirology; 2012 Jan; 9():5. PubMed ID: 22240256
[TBL] [Abstract][Full Text] [Related]
10. Higher SLPI expression, lower immune activation, and increased frequency of immune cells in a cohort of Colombian HIV-1 controllers.
Taborda NA; Cataño JC; Delgado JC; Rugeles MT; Montoya CJ
J Acquir Immune Defic Syndr; 2012 May; 60(1):12-9. PubMed ID: 22240462
[TBL] [Abstract][Full Text] [Related]
11. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy.
Pereyra F; Addo MM; Kaufmann DE; Liu Y; Miura T; Rathod A; Baker B; Trocha A; Rosenberg R; Mackey E; Ueda P; Lu Z; Cohen D; Wrin T; Petropoulos CJ; Rosenberg ES; Walker BD
J Infect Dis; 2008 Feb; 197(4):563-71. PubMed ID: 18275276
[TBL] [Abstract][Full Text] [Related]
12. Highly divergent patterns of genetic diversity and evolution in proviral quasispecies from HIV controllers.
de Azevedo SSD; Caetano DG; Côrtes FH; Teixeira SLM; Dos Santos Silva K; Hoagland B; Grinsztejn B; Veloso VG; Morgado MG; Bello G
Retrovirology; 2017 May; 14(1):29. PubMed ID: 28464889
[TBL] [Abstract][Full Text] [Related]
13. HIV Antibody Profiles in HIV Controllers and Persons With Treatment-Induced Viral Suppression.
Kammers K; Chen A; Monaco DR; Hudelson SE; Grant-McAuley W; Moore RD; Alter G; Deeks SG; Morrison CS; Eller LA; Blankson JN; Laeyendecker O; Ruczinski I; Eshleman SH; Larman HB
Front Immunol; 2021; 12():740395. PubMed ID: 34512672
[TBL] [Abstract][Full Text] [Related]
14. Evidence for innate immune system activation in HIV type 1-infected elite controllers.
Krishnan S; Wilson EM; Sheikh V; Rupert A; Mendoza D; Yang J; Lempicki R; Migueles SA; Sereti I
J Infect Dis; 2014 Mar; 209(6):931-9. PubMed ID: 24185941
[TBL] [Abstract][Full Text] [Related]
15. Immune and viral correlates of "secondary viral control" after treatment interruption in chronically HIV-1 infected patients.
Van Gulck E; Bracke L; Heyndrickx L; Coppens S; Atkinson D; Merlin C; Pasternak A; Florence E; Vanham G
PLoS One; 2012; 7(5):e37792. PubMed ID: 22666392
[TBL] [Abstract][Full Text] [Related]
16. Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers.
Ferre AL; Lemongello D; Hunt PW; Morris MM; Garcia JC; Pollard RB; Yee HF; Martin JN; Deeks SG; Shacklett BL
J Virol; 2010 Oct; 84(19):10354-65. PubMed ID: 20668079
[TBL] [Abstract][Full Text] [Related]
17. HIV-specific CD4+ T cells may contribute to viral persistence in HIV controllers.
Hunt PW; Hatano H; Sinclair E; Lee TH; Busch MP; Martin JN; McCune JM; Deeks SG
Clin Infect Dis; 2011 Mar; 52(5):681-7. PubMed ID: 21245154
[TBL] [Abstract][Full Text] [Related]
18. Identification of NK Cell Subpopulations That Differentiate HIV-Infected Subject Cohorts with Diverse Levels of Virus Control.
Pohlmeyer CW; Gonzalez VD; Irrinki A; Ramirez RN; Li L; Mulato A; Murry JP; Arvey A; Hoh R; Deeks SG; Kukolj G; Cihlar T; Pflanz S; Nolan GP; Min-Oo G
J Virol; 2019 Apr; 93(7):. PubMed ID: 30700608
[TBL] [Abstract][Full Text] [Related]
19. Learning to Be Elite: Lessons From HIV-1 Controllers and Animal Models on Trained Innate Immunity and Virus Suppression.
Sugawara S; Reeves RK; Jost S
Front Immunol; 2022; 13():858383. PubMed ID: 35572502
[TBL] [Abstract][Full Text] [Related]
20. Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parameters.
Pereyra F; Palmer S; Miura T; Block BL; Wiegand A; Rothchild AC; Baker B; Rosenberg R; Cutrell E; Seaman MS; Coffin JM; Walker BD
J Infect Dis; 2009 Sep; 200(6):984-90. PubMed ID: 19656066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
